Tower Research Capital (TRC)’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.9K Buy
2025
Q1
$5.7K Buy
2024
Q4
Sell
2024
Q3
$84.3K Buy
2024
Q2
$2.07K Sell
2024
Q1
$14K Buy
2023
Q4
$3.92K Sell
2023
Q3
$10.9K Sell
2023
Q2
$46.5K Buy
2022
Q3
Sell
2022
Q2
$0 Buy
2022
Q1
Sell
2021
Q4
$2K Buy
2021
Q3
$1K Buy
2021
Q2
$0 Buy
2021
Q1
Sell
2020
Q4
$0 Buy